December 19th 2008 | Biologics, Treatment | 0 Comments
Statement issued today from Centocor about Stelara (ustekinumab):
Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its Biologics License Application (BLA) for ustekinumab. …
The Complete Response letter requests additional information, including a proposal by Centocor for a Risk Evaluation and Mitigation Strategy (REMS). … The ustekinumab
READ THE FULL POST
December 11th 2008 | Patient Stories | 0 Comments
Have you checked out Kevin’s profile on our 2008 Calendar website? Kevin has a hard time living with psoriasis. It’s a story that will be painfully familiar to many, many people living with psoriasis.
We’re grateful that Kevin was willing to speak so candidly about his feelings. Let’s hope he and everyone else
READ THE FULL POST
